Ethyl 7-methyl-1-(4-nitrophenyl)-5-phenyl-3- (thiophen-2-yl)-1,5-dihydro-[1,2,4]triazolo [4,3-a]pyrimidine-6-carboxylate

4Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

Abstract

A novel compound, ethyl 7-methyl-1-(4-nitrophenyl)-5-phenyl-3-(thiophen-2-yl)-1,5- dihydro[1,2,4]triazolo[4,3-a]pyrimidine-6-carboxylate (7) was synthesized by reaction of N-(4- nitrophenyl)thiophene-2-carbohydrazonoyl chloride (1) with ethyl 6-methyl-4-phenyl-2-thioxo- 1,2,3,4-tetrahydropyrimidine-5-carboxylate (2). The mechanism of the studied reaction is discussed and the assigned structure was confirmed by elemental analysis and spectral data. Moreover, the in vitro antitumor activities against human lung (A-549) and human hepatocellular carcinoma (HepG-2) cell lines were determined by the MTT method, and the results indicated a high potency compared with the employed standard antitumor drug (Cisplatin).

Cite

CITATION STYLE

APA

Gomha, S. M., Muhammad, Z. A., & Edrees, M. M. (2017, June 1). Ethyl 7-methyl-1-(4-nitrophenyl)-5-phenyl-3- (thiophen-2-yl)-1,5-dihydro-[1,2,4]triazolo [4,3-a]pyrimidine-6-carboxylate. MolBank. MDPI AG. https://doi.org/10.3390/M942

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free